Many Americans unaware of lifestyle factors that increase cancer risk
the ONA take:
According to a new survey conducted by the American Institute for Cancer Research (AICR), researchers have found that fewer than half of Americans are aware that certain major lifestyle factors can increase their risk of developing cancer, and instead worry about cancer-causing claims that lack scientific evidence.
For the study, researchers polled more than 1,100 U.S. adults about their awareness of lifestyle risk factors for cancer. Results showed that only a minority of participants were aware that diets high in red meat or low in fruits and vegetables, obesity, and physical inactivity can increase a person's risk for developing cancer.
The study also found that more Americans are concerned about cancer-causing hormones in food and stress that have no scientific evidence to support those claims.
Specifically, 54 to 62% of participants reported that they believe food additives, genetically modified foods, hormones in beef, and psychological stress increase cancer risk. Over half of respondents believed artificial sweeteners cause cancer.
Fewer than half of Americans are aware that certain major lifestyle factors can increase their risk of developing cancer.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Immune Thrombocytopenia (Fact Sheet)
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|